We are live on ! Find out more
MLAB icon

Mesa Laboratories

160 hedge funds and large institutions have $833M invested in Mesa Laboratories in 2022 Q4 according to their latest regulatory filings, with 25 funds opening new positions, 64 increasing their positions, 49 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 49

22% more capital invested

Capital invested by funds: $681M → $833M (+$152M)

4.22% more ownership

Funds ownership: 91%95.22% (+4.2%)

9% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 23

2% less funds holding

Funds holding: 163160 (-3)

Holders
160
Holders Change
-3
Holders Change %
-1.84%
% of All Funds
2.57%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
25
Increased
64
Reduced
49
Closed
23
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Russell Investments Group
26
Russell Investments Group
United Kingdom
$6.64M -$2M -12,757 -24%
Charles Schwab
27
Charles Schwab
California
$6.35M +$211K +1,347 +4%
GIM
28
Granahan Investment Management
Massachusetts
$5.63M -$157K -1,001 -3%
Bank of America
29
Bank of America
North Carolina
$5.39M +$444K +2,834 +10%
Royal Bank of Canada
30
Royal Bank of Canada
Ontario, Canada
$5.37M +$916K +5,844 +22%
KLC
31
Kent Lake Capital
Nevada
$4.69M +$4.42M +28,204 New
KCM
32
Kennedy Capital Management
Missouri
$3.82M +$3.6M +22,956 New
N
33
Nuveen
North Carolina
$3.16M -$34.9K -223 -1%
Ohio Public Employees Retirement System (OPERS)
34
Ohio Public Employees Retirement System (OPERS)
Ohio
$3.14M +$417K +2,664 +16%
Renaissance Technologies
35
Renaissance Technologies
New York
$2.98M +$1.53M +9,734 +119%
Goldman Sachs
36
Goldman Sachs
New York
$2.69M +$1.46M +9,326 +135%
AllianceBernstein
37
AllianceBernstein
Tennessee
$2.41M +$1.1K +7 +0%
RHJA
38
Rice Hall James & Associates
California
$2.37M -$97.5K -622 -4%
RhumbLine Advisers
39
RhumbLine Advisers
Massachusetts
$2.33M +$34.5K +220 +2%
Luther King Capital Management (LKCM)
40
Luther King Capital Management (LKCM)
Texas
$2.31M
JP Morgan Chase
41
JP Morgan Chase
New York
$2.21M -$27.6K -176 -1%
Swiss National Bank
42
Swiss National Bank
Switzerland
$2.13M +$62.7K +400 +3%
Legal & General Group
43
Legal & General Group
United Kingdom
$2.11M +$50.6K +323 +3%
Envestnet Asset Management
44
Envestnet Asset Management
Illinois
$2.09M +$208K +1,327 +12%
MAP
45
Moody Aldrich Partners
Massachusetts
$1.9M -$1.86M -11,884 -51%
CS
46
Credit Suisse
Switzerland
$1.52M +$257K +1,638 +22%
Public Sector Pension Investment Board (PSP Investments)
47
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.52M
Victory Capital Management
48
Victory Capital Management
Texas
$1.51M -$699K -4,464 -33%
MFAM
49
Motley Fool Asset Management
Virginia
$1.42M -$117K -744 -8%
SEI Investments
50
SEI Investments
Pennsylvania
$1.21M -$179K -1,142 -14%

MLAB Hedge Fund Activity: Q4 2022 in Review

160 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Mesa Laboratories (MLAB) for Q4 2022, worth a combined $833M — up 22% from $681M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new MLAB positions and 23 closed out — a net gain of 2 holders — while 64 added to existing stakes and 49 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $36.8M. The largest seller was Royce & Associates, cutting an estimated $14.2M.

  • 160 institutional investors held Mesa Laboratories (MLAB) as of Q4 2022, down from 163 in Q3 2022.
  • Funds reported $833M of Mesa Laboratories stock for Q4 2022, up 22% quarter-over-quarter.
  • 25 funds opened new Mesa Laboratories positions in Q4 2022 and 23 closed out, a net change of +2 holders.
  • The largest Mesa Laboratories buyer in Q4 2022 was Morgan Stanley, an estimated $36.8M added.
  • The largest Mesa Laboratories seller in Q4 2022 was Royce & Associates, an estimated $14.2M sold.

Based on aggregated 13F filings for Q4 2022.